First-in-human, phase I dose-escalation study of single and multiple doses of a first-in-class enhancer of fluoropyrimidines, a dUTPase inhibitor (TAS-114) in healthy male volunteers (Q87146227)
Jump to navigation
Jump to search
scientific article published on 23 January 2014
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | First-in-human, phase I dose-escalation study of single and multiple doses of a first-in-class enhancer of fluoropyrimidines, a dUTPase inhibitor (TAS-114) in healthy male volunteers |
scientific article published on 23 January 2014 |
Statements
First-in-human, phase I dose-escalation study of single and multiple doses of a first-in-class enhancer of fluoropyrimidines, a dUTPase inhibitor (TAS-114) in healthy male volunteers (English)
Kaku Saito
Hirotaka Nagashima
Kazuharu Noguchi
Kunihiro Yoshisue
Tatsushi Yokogawa
Eiji Matsushima
Takeshi Tahara